Stage 2 Mesothelioma

Stage 2 mesothelioma means cancer cells may not have spread far, but they are entering nearby lymph nodes. Prognosis at stage 2 may still be favorable, and there are plenty of treatments available to extend life expectancy. The 2-year survival rate for some patients at this stage is around 38 percent.

Free Mesothelioma Treatment Guide

Written By

Edited By

Medical Review By

This page features: 11 cited research articles

In stage 2, tumors have developed in the pleura (the protective tissue lining around the lungs). The cancer may have started to grow into the breathing muscle under the lungs (the diaphragm) or into the lung tissue itself.

There is one main difference between stage 1 and stage 2 pleural mesothelioma. By the second stage, cancer cells have begun to spread into lymph nodes near the main tumor site.

Your lymph nodes are a series of filters that keep germs out of your bloodstream. Once cancer cells reach the lymphatic system, they can spread into the bloodstream and throughout the body.

Once mesothelioma cells have spread to lymph nodes, the case is considered stage 2 or higher, even if the main tumor growths are still very small.

Peritoneal mesothelioma has no formal staging system. Doctors often define it as stage 2 if there is local tumor growth and some lymph node involvement.

Stage 2 patients can benefit from an approach called multimodal therapy. They must be healthy enough to endure an aggressive treatment plan.

Multimodal therapy combines tumor-removing surgery with chemotherapy and radiation therapy. This combination is currently the gold standard for mesothelioma treatment. It has helped some patients live years beyond the average prognosis.

Early-stage patients often have a number of promising experimental therapies available to them as well.

Stage 2 mesothelioma tumor progression

Stage 2 Mesothelioma Facts

  • Two-year survival rate is about 38 percent
  • Typically causes no major symptoms
  • Tumor-removing surgery recommended for eligible patients
  • Surgery is usually supported by chemotherapy and radiation therapy

Early Signs of Mesothelioma

Stage 2 mesothelioma symptoms

  • Chronic coughing
  • Breathing difficulty
  • Chest pain
  • Fever

In most cases, stage 2 mesothelioma does not cause symptoms.

If symptoms do arise, they are easily mistaken for signs of the flu or pneumonia. The discomfort stems from tumor growth or a buildup of fluid in the pleura (known as pleural effusion) constricting the lung.

Some stage 2 cases are discovered through cancer screening. More often they are caught by accident when a doctor checks a patient’s chest for an unrelated reason.

Mesothelioma has a long latency period. Decades pass before the cancer even begins to develop. Once it begins to develop, it grows quickly without causing symptoms until stage 3 or 4. Most mesothelioma cases are diagnosed after the cancer has already advanced beyond stage 2.

Find a Mesothelioma Specialist Near You

Connect with a specialist who can confirm your stage and create a treatment plan for you or a loved on.

Get Help Now

Defining Stage 2 Mesothelioma

Doctors have developed three staging systems for pleural mesothelioma. The TNM system is the most commonly used today. The three systems use different definitions for stage 2.

  • TNM Staging System: Mesothelioma is in the pleura on one side of the chest, and it may have begun to spread into tissue in the lung or diaphragm. Cancer has also spread to nearby lymph nodes, but it has not spread to distant sites.

  • Brigham Staging System: Tumors are confined to the pleural lining of the lungs, and nearby lymph nodes are cancerous.

  • Butchart Staging System: Cancer has grown from the pleura into the chest wall. It may also have spread into the diaphragm, the organs between the lungs, or the lymph nodes of the chest.

Learn more about mesothelioma staging systems

Stage 2 Mesothelioma Treatments

Stage 2 mesothelioma is treated with surgery, chemotherapy and radiation therapy.

Even with minor lymph node involvement, there are effective treatment options available to early-stage mesothelioma patients. Clinical trials offer experimental treatments such as immunotherapy.

  • Surgery icon

    Surgery

    There are two main surgical options for removing pleural mesothelioma tumors. The difference comes down to whether or not surgeons have to remove one of the patient’s lungs to eliminate all the cancer.

    Each patient’s medical team must create a treatment plan based on the patient’s overall health and how far the cancer has spread.

    Learn more about mesothelioma surgery

  • Chemotherapy icon

    Chemotherapy

    The chemotherapy drugs Alimta and cisplatin are the most common treatment for mesothelioma.

    Doctors may use drugs to shrink tumors before surgery or kill remaining cancer cells after surgery. Patients not eligible for surgery may benefit from chemotherapy as a solo treatment.

    Learn more about chemotherapy treatment

  • Radiation therapy icon

    Radiation Therapy

    Radiation can also be used to shrink tumors before surgery or prevent local recurrence after surgery.

    Learn more about radiation therapy treatment

  • Clinical trials icon

    Clinical Trials

    Patients can access new therapies the U.S. Food and Drug Administration has not yet approved through clinical trials. These trials test immunotherapy, gene therapy and novel combinations of chemotherapy drugs.

    Patients often have to be relatively healthy to volunteer for these research studies. Many people diagnosed with stage 2 mesothelioma qualify for clinical trials.

    Learn more about mesothelioma clinical trials

Dr. Jacques Fontaine describes mesothelioma surgery and who are the best candidates for this type of treatment.

Is Stage 2 Mesothelioma Curable?

Unfortunately, no stage of mesothelioma is curable. But therapies can control the cancer to help people live with mesothelioma.

Pleural mesothelioma is an aggressive disease. Most patients do not survive longer than two years after diagnosis. Stage 2 mesothelioma carries a better prognosis than more advanced stages of the cancer.

Doctors and researchers are testing new drugs in hopes of finding a way to control and ultimately defeat mesothelioma.

Many mesothelioma specialists are also trying to perfect their treatment strategies. The goal is to help patients manage the cancer as a chronic disease rather than a terminal illness. Their efforts have resulted in some fortunate mesothelioma survivors outliving the average life expectancy for mesothelioma by years.

Life Expectancy for Stage 2 Mesothelioma

Pleural Mesothelioma Stage 2 Survival Rates
  2-year survival rate 5-year survival rate

Stage 2

38%

10%

About 38 percent of stage 2 mesothelioma patients live longer than two years.

Researchers calculate what percentage of stage 2 patients survived at least two years and at least five years. This is based on the statistics from thousands of patients diagnosed in recent years.

These survival rates reveal the seriousness of this diagnosis. But because every patient is different and treatment technology has changed since these statistics were collected, these survival rates cannot predict the outcome for an individual patient.

An individual patient’s life expectancy depends on many factors. Their overall health and the specific cell type of their cancer play important roles.

Are You Feeling Overwhelmed by Mesothelioma?

We Can Help
Asbestos.com Mesothelioma Packet

Get Answers in Our Free Mesothelioma Guide

Order Yours Now

Our Patient Advocates Help Get the Resources You Need

Connect With Us

Get Answers to Your Mesothelioma Questions

Get Your Free Mesothelioma Guide

Connect With a Trusted Patient Advocate

Did this article help you?

Did this article help you?

Thank you for your feedback. Would you like to speak with a Patient Advocate?


Karen Selby, RN and Patient Advocate at The Mesothelioma Center

Karen Selby joined Asbestos.com in 2009. She is a registered nurse with a background in oncology and thoracic surgery and was the director of a tissue bank before becoming a Patient Advocate at The Mesothelioma Center. Karen has assisted surgeons with thoracic surgeries such as lung resections, lung transplants, pneumonectomies, pleurectomies and wedge resections. She is also a member of the Academy of Oncology Nurse & Patient Navigators. Read More

Matt Mauney, Content Writer at Asbestos.com

Edited by

Reviewed by placeholder

Medical Review By

Last Modified July 3, 2018
Sources
  1. American Cancer Society. (2017, December 20). Malignant Mesothelioma Stages. 

  2. Retrieved from: https://www.cancer.org/cancer/malignant-mesothelioma/detection-diagnosis-staging/staging.html
  3. American Cancer Society. (2017, December 20). Survival Statistics for Mesothelioma. 

  4. Retrieved from: https://www.cancer.org/cancer/malignant-mesothelioma/detection-diagnosis-staging/survival-statistics.html
  5. Rusch, V. (2017). Update on the mesothelioma staging system. Journal of Thoracic Oncology; 12(1):S30-S31. doi: 10.1016/j.jtho.2016.11.031
  6. Cho, B.C.J. et al. (2014). A feasibility study evaluating surgery for mesothelioma after radiation therapy: The SMART approach for resectable malignant pleural mesothelioma. Journal of Thoracic Oncology, 9(3): 397-402. doi: 10.1097/JTO.0000000000000078
  7. National Comprehensive Cancer Network. (2014). NCCN Guidelines for Patients: Malignant Pleural Mesothelioma. 

  8. Retrieved from: http://www.nccn.org/patients/guidelines/mpm/index.html
  9. Rusch, V.W. & Giroux, D. (2012). Do we need a revised staging system for malignant pleural mesothelioma? Analysis of the IASLC database. Annals of Cardiothoracic Surgery, 1(4): 438-448. doi: 10.3978/j.issn.2225-319X.2012.11.10
  10. Rusch, V.W. et al. (2012). Initial analysis of the international association for the study of lung cancer mesothelioma database. Journal of Thoracic Oncology, 7(11): 1631-1639. doi: 10.1097/JTO.0b013e31826915f1
  11. Tannapfel, A. (2011). Malignant Mesothelioma: Recent Results in Cancer Research. Springer: Berlin.
  12. Yan, T., Cao, C. & Munkholm-Larsen, S. (2010, February 15). A Pharmacological Review on Intraperitoneal Chemotherapy for Peritoneal Malignancy. World Journal of Gastrointestinal Oncology. 

  13. Retrieved from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2999163/?tool=pmcentrez
  14. Schil, P.V. et al. (2008). Staging of malignant pleural mesothelioma. In Baldi, A. (Ed.), Mesothelioma from Bench Side to Clinic (357-366). New York: Nova Science Publishers, Inc.
Topics on This Page
Back to Top
Chat live with a patient advocate now loading spinner